The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline hydrochloride extended-release capsules, to be used in the treatment ...
Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand ...
(RTTNews) - Journey Medical (DERM) announced the FDA has approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed in collaboration with Dr. Reddy's ...
There are self-care strategies that may aid in helping to prevent prostate cancer, the third most common cause of cancer-related death in men. Located below the bladder, the prostate is the gland ...
which is also only approved for the treatment of inflammatory lesions in rosacea but has become the standard treatment in the US. Another consideration is that the first generic versions of Oracea ...
In addition to Oracea, Journey’s rosacea offering could rival Sol-Gel Technologies’ Galderma-partnered Epsolay, a topical medicine that won approval in 2022. That treatment option uses Sol-Gel ...
Here’s what we know about zinc, honey and ginger — and other popular remedies that show at least ... ginger and turmeric A sore throat is often the natural result of inflammation created ...
Cranberry products, including juices and extracts, are among the most popular choices for natural and alternative treatments for UTIs. Cranberries contain a wide variety of chemical compounds ...